"Can Do" Versus "Do Do" in Patients With Breast Cancer
Launched by HACETTEPE UNIVERSITY · Aug 24, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Can Do" Versus "Do Do" is exploring how physical activity affects women who have been treated for breast cancer. Researchers want to understand how different levels of exercise and physical ability can impact the overall health and quality of life of these patients. They will use a simple test called the 6-minute walk test to measure how far participants can walk in that time, which helps assess their fitness levels. By categorizing patients based on their physical activity and ability, the study aims to find out if there are differences in health and functioning among women with varying levels of fitness.
To join this study, women aged 18 to 65 who are at least 15 months post-breast cancer surgery and six months after finishing active treatment may be eligible. Participants will need to be able to understand and cooperate with the tests, and they should not have any current infections or serious health issues that could affect their ability to exercise. Those who take part can expect to engage in physical tests and share information about their health and daily activities, which will help researchers better understand the challenges breast cancer survivors face in staying active and healthy.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Being between 18-65 years of age,
- • 2. Volunteering to participate in the research,
- • 3. At least 15 months after breast cancer surgery,
- • 4. Six months after active breast cancer treatment (i.e. surgery/chemotherapy),
- • 5. No problems in reading and/or understanding the scales and being able to cooperate with the tests,
- Exclusion Criteria:
- • 1. Presence of active infection,
- • 2. Musculoskeletal and neurological diseases that may affect exercise performance, symptomatic heart disease,
- • 3. Have a neurological disease or other clinical diagnosis that may affect cognitive status.
- • 4. Musculoskeletal and neurologic disease, symptomatic heart disease, previous lung surgery and malignant disease that may affect exercise performance.
- • 5. Presence of unstable hypertension or diabetes mellitus
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Hacettepe Unıversity, Turkey
Ankara, , Turkey
Patients applied
Trial Officials
Ebru Calik-Kutukcu, PhD
Principal Investigator
Hacettepe University
Melda Saglam, PhD
Study Chair
Hacettepe University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported